Kailera Therapeutics, Inc. 4 Filing
Ticker: KLRA · Form: 4 · Filed: Apr 20, 2026 · CIK: 0002096997
| Field | Detail |
|---|---|
| Company | Kailera Therapeutics, Inc. (KLRA) |
| Form Type | 4 |
| Filed Date | Apr 20, 2026 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 4 filing submitted by Kailera Therapeutics, Inc. (ticker: KLRA) to the SEC on Apr 20, 2026.
Where can I view the full 4 filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 20, 2026 regarding Kailera Therapeutics, Inc. (KLRA). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.